First Tracks Biotherapeutics, Inc. ·
TRAX 8-K 2026-11-03
First Tracks Biotherapeutics, Inc. (TRAX) 8-K dated 2026-11-03 — accession 0001193125-26-445405.
First Tracks Biotherapeutics, Inc. (TRAX) common stock.
First Tracks Biotherapeutics, Inc. filed a 8-K on 2026-11-03. Accession 0001193125-26-445405.
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Income-statement cache for TRAX is thin on this filing URL. We will not invent exhibit numbers.
Not investment advice. The TRAX SEC hub lists recent forms. The stock page is the research view.